A new type of long-term potentiation that is controlled by kainate receptors has been reported by scientists at the University of Bristol and the University of Central Lancashire. The finding could have major benefits to understanding how the brain works and what goes wrong in neurodegenerative disorders such as epilepsy and dementia.
Human brains contain around 100-billion nerve cells, each of which makes about 10,000 connections to other cells, called synapses. Synapses are constantly transmitting information to, and receiving information from other nerve cells.
The process known as long-term potentiation (LTP), increases the strength of information flow across synapses, and is crucial to the process of forming memories. Having a large number of synapses communicating between different nerve cells forms networks. LTP intensifies the connectivity of the cells in the network to make information transfer more efficient.
This LTP mechanism is how the brain operates at the cellular level to allow us to learn and remember. However, when these processes go wrong they can lead to neurological and neurodegenerative disorders.
Kainate Receptor Long-term Potentiation
Exactly how LTP is initiated is a major question in neuroscience. Traditional long-term potentiation is regulated by the activation of special proteins at synapses called NMDA receptors. This study, by Professor Jeremy Henley and co-workers, details a new form of LTP controlled by kainate receptors.
Henley, Professor of Molecular Neuroscience in Bristol’s School of Biochemistry in the Faculty of Medical and Veterinary Sciences, said:
“These discoveries represent a significant advance and will have far-reaching implications for the understanding of memory, cognition, developmental plasticity and neuronal network formation and stabilisation. In summary, we believe that this is a groundbreaking study that opens new lines of inquiry which will increase understanding of the molecular details of synaptic function in health and disease.”
The advance highlights the flexibility in the way synapses are controlled and nerve cells communicate. This, in turn, raises the possibility of targeting this new pathway to develop therapeutic strategies for diseases like dementia, in which there is too little synaptic transmission and LTP, and epilepsy where there is too much inappropriate synaptic transmission and LTP.
The findings will have far-reaching implications in many aspects of neuroscience. Dr Milos Petrovic, co-author of the study and Reader in Neuroscience at the University of Central Lancashire added:
“Untangling the interactions between the signal receptors in the brain not only tells us more about the inner workings of a healthy brain, but also provides a practical insight into what happens when we form new memories. If we can preserve these signals it may help protect against brain diseases.
This is certainly an extremely exciting discovery and something that could potentially impact the global population. We have discovered potential new drug targets that could help to cure the devastating consequences of dementias, such as Alzheimer’s disease. Collaborating with researchers across the world in order to identify new ways to fight disease like this is what world-class scientific research is all about, and we look forward to continuing our work in this area.”
The new pathway involves the metabotropic action of kainate receptors and activation of G protein, protein kinase C and phospholipase C. Kainate-receptor-dependent long-term potentiation enhances synaptic recycling of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors to increase surface expression, and elicits structural changes in neural spines, such as increased growth and maturation.